Advertisement

Index by Author

September 1992; 41 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alyassin, A M

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  2. Antonipillai, I

    • Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats. Diabetes September 1992 41:1100-1105; doi:10.2337/diabetes.41.9.1100

B

  1. Bain, S C

    • A practical approach to identification of susceptibility genes for IDDM. Diabetes September 1992 41:1029-1034; doi:10.2337/diabetes.41.9.1029

  2. Baron, A D

    • Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes September 1992 41:1076-1083; doi:10.2337/diabetes.41.9.1076

  3. Beloff-Chain, A

    • Elevated plasma concentrations of beta-cell tropin (ACTH22-39) in diet-treated type II diabetic patients. Diabetes September 1992 41:1160-1164; doi:10.2337/diabetes.41.9.1160

  4. Bennett, P H

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  5. Boden, G

    • Effects of oleate and insulin on glucose uptake, oxidation, and glucose transporter proteins in rat adipocytes. Diabetes September 1992 41:1063-1068; doi:10.2337/diabetes.41.9.1063

  6. Bonadonna, R C

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  7. Bonora, E

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  8. Bowsher, R R

    • A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes September 1992 41:1084-1090; doi:10.2337/diabetes.41.9.1084

  9. Brechtel, G

    • Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes September 1992 41:1076-1083; doi:10.2337/diabetes.41.9.1076

  10. Bylander, J E

    • Variation in sorbitol accumulation and polyol-pathway activity in cultured human proximal tubule cells. Diabetes September 1992 41:1050-1055; doi:10.2337/diabetes.41.9.1050

C

  1. Charles, M A

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  2. Chonko, A M

    • Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes September 1992 41:1035-1041; doi:10.2337/diabetes.41.9.1035

  3. Cooper, H N

    • Growth of neonatal islet transplants in the spontaneously diabetic BB/Wor rat. Diabetes September 1992 41:1122-1129; doi:10.2337/diabetes.41.9.1122

  4. Cram, D S

    • An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes September 1992 41:1182-1187; doi:10.2337/diabetes.41.9.1182

D

  1. Davenport, M

    • Elevated plasma concentrations of beta-cell tropin (ACTH22-39) in diet-treated type II diabetic patients. Diabetes September 1992 41:1160-1164; doi:10.2337/diabetes.41.9.1160

  2. DeAizpurua, H J

    • An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes September 1992 41:1182-1187; doi:10.2337/diabetes.41.9.1182

  3. Del Prato, S

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  4. Deluca, F

    • Effects of oleate and insulin on glucose uptake, oxidation, and glucose transporter proteins in rat adipocytes. Diabetes September 1992 41:1063-1068; doi:10.2337/diabetes.41.9.1063

  5. Donaldson, D L

    • Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes September 1992 41:1035-1041; doi:10.2337/diabetes.41.9.1035

E

  1. Edelman, S V

    • Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes September 1992 41:1076-1083; doi:10.2337/diabetes.41.9.1076

  2. Ellis, E N

    • Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat. Diabetes September 1992 41:1106-1112; doi:10.2337/diabetes.41.9.1106

  3. Esmeraldo, R

    • A new method for quantification of islets by measurement of zinc content. Diabetes September 1992 41:1056-1062; doi:10.2337/diabetes.41.9.1056

F

  1. Finegood, D T

    • Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes September 1992 41:1172-1181; doi:10.2337/diabetes.41.9.1172

  2. Flath, M C

    • Variation in sorbitol accumulation and polyol-pathway activity in cultured human proximal tubule cells. Diabetes September 1992 41:1050-1055; doi:10.2337/diabetes.41.9.1050

  3. Flier, J S

    • Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again. Diabetes September 1992 41:1207-1219; doi:10.2337/diabetes.41.9.1207

  4. Frank, B H

    • A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes September 1992 41:1084-1090; doi:10.2337/diabetes.41.9.1084

  5. Futterweit, S

    • Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. Diabetes September 1992 41:1130-1140; doi:10.2337/diabetes.41.9.1130

G

  1. Ghiatas, A A

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  2. Goncharov, V G

    • Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes September 1992 41:1042-1049; doi:10.2337/diabetes.41.9.1042

  3. Goodyear, L J

    • Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes September 1992 41:1091-1099; doi:10.2337/diabetes.41.9.1091

  4. Grady, E F

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  5. Gray, D W

    • A new method for quantification of islets by measurement of zinc content. Diabetes September 1992 41:1056-1062; doi:10.2337/diabetes.41.9.1056

  6. Griffin, C A

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  7. Grunfeld, C

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  8. Gulli, G

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  9. Gyda, M

    • Effects of oleate and insulin on glucose uptake, oxidation, and glucose transporter proteins in rat adipocytes. Diabetes September 1992 41:1063-1068; doi:10.2337/diabetes.41.9.1063

H

  1. Haneda, M

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  2. Harrison, L C

    • An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes September 1992 41:1182-1187; doi:10.2337/diabetes.41.9.1182

  3. Hegre, O D

    • Growth of neonatal islet transplants in the spontaneously diabetic BB/Wor rat. Diabetes September 1992 41:1122-1129; doi:10.2337/diabetes.41.9.1122

  4. Hirshman, M F

    • Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes September 1992 41:1091-1099; doi:10.2337/diabetes.41.9.1091

  5. Horton, E S

    • Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes September 1992 41:1091-1099; doi:10.2337/diabetes.41.9.1091

  6. Horton, R

    • Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats. Diabetes September 1992 41:1100-1105; doi:10.2337/diabetes.41.9.1100

I

  1. Ideus, P

    • Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes September 1992 41:1035-1041; doi:10.2337/diabetes.41.9.1035

J

  1. Jindal, R M

    • A new method for quantification of islets by measurement of zinc content. Diabetes September 1992 41:1056-1062; doi:10.2337/diabetes.41.9.1056

  2. Jost-Vu, E

    • Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats. Diabetes September 1992 41:1100-1105; doi:10.2337/diabetes.41.9.1100

K

  1. Kajiwara, N

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  2. Kalinyak, J E

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  3. Kemmer, K A

    • Growth of neonatal islet transplants in the spontaneously diabetic BB/Wor rat. Diabetes September 1992 41:1122-1129; doi:10.2337/diabetes.41.9.1122

  4. Kikkawa, R

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  5. Kilcoyne, R F

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  6. Knowler, W C

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  7. Kovalev, P A

    • Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes September 1992 41:1042-1049; doi:10.2337/diabetes.41.9.1042

  8. Kuikka, J

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

L

  1. Laakso, M

    • Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes September 1992 41:1076-1083; doi:10.2337/diabetes.41.9.1076

  2. Lacković, Z

    • Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes September 1992 41:1119-1121; doi:10.2337/diabetes.41.9.1119

  3. Lancaster, J L

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  4. Länsimies, E

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

  5. Levy, J C

    • Elevated plasma concentrations of beta-cell tropin (ACTH22-39) in diet-treated type II diabetic patients. Diabetes September 1992 41:1160-1164; doi:10.2337/diabetes.41.9.1160

  6. Lewis, J T

    • Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes September 1992 41:1172-1181; doi:10.2337/diabetes.41.9.1172

  7. Liebow, I M

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  8. Liu, Q Z

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

M

  1. Maeda, S

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  2. Mäntysaari, M

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

  3. Moore, W V

    • Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes September 1992 41:1035-1041; doi:10.2337/diabetes.41.9.1035

  4. Morris, P J

    • A new method for quantification of islets by measurement of zinc content. Diabetes September 1992 41:1056-1062; doi:10.2337/diabetes.41.9.1056

  5. Morton, J L

    • Elevated plasma concentrations of beta-cell tropin (ACTH22-39) in diet-treated type II diabetic patients. Diabetes September 1992 41:1160-1164; doi:10.2337/diabetes.41.9.1160

  6. Murer, E

    • Effects of oleate and insulin on glucose uptake, oxidation, and glucose transporter proteins in rat adipocytes. Diabetes September 1992 41:1063-1068; doi:10.2337/diabetes.41.9.1063

  7. Mustonen, J

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

N

  1. Nelson, R G

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  2. Nishimura, C

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

P

  1. Pettitt, D J

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

R

  1. Rajotte, R V

    • Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes September 1992 41:1172-1181; doi:10.2337/diabetes.41.9.1172

S

  1. Saad, M F

    • Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes September 1992 41:1141-1150; doi:10.2337/diabetes.41.9.1141

  2. Salković, M

    • Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes September 1992 41:1119-1121; doi:10.2337/diabetes.41.9.1119

  3. Savin, V J

    • Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat. Diabetes September 1992 41:1106-1112; doi:10.2337/diabetes.41.9.1106

  4. Schambelan, M

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  5. Sechi, L A

    • Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes September 1992 41:1113-1118; doi:10.2337/diabetes.41.9.1113

  6. Sens, D A

    • Variation in sorbitol accumulation and polyol-pathway activity in cultured human proximal tubule cells. Diabetes September 1992 41:1050-1055; doi:10.2337/diabetes.41.9.1050

  7. Serie, J R

    • Growth of neonatal islet transplants in the spontaneously diabetic BB/Wor rat. Diabetes September 1992 41:1122-1129; doi:10.2337/diabetes.41.9.1122

  8. Shank, M L

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  9. Shigeta, Y

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  10. Shishko, P I

    • Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes September 1992 41:1042-1049; doi:10.2337/diabetes.41.9.1042

  11. Solini, A

    • Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes September 1992 41:1151-1159; doi:10.2337/diabetes.41.9.1151

  12. Sturman, J A

    • Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. Diabetes September 1992 41:1130-1140; doi:10.2337/diabetes.41.9.1130

T

  1. Tahvanainen, K

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

  2. Taylor, R P

    • A new method for quantification of islets by measurement of zinc content. Diabetes September 1992 41:1056-1062; doi:10.2337/diabetes.41.9.1056

  3. Tobin, B L

    • Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes September 1992 41:1172-1181; doi:10.2337/diabetes.41.9.1172

  4. Tobin, B W

    • Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes September 1992 41:1172-1181; doi:10.2337/diabetes.41.9.1172

  5. Todd, J A

    • A practical approach to identification of susceptibility genes for IDDM. Diabetes September 1992 41:1029-1034; doi:10.2337/diabetes.41.9.1029

  6. Trachtman, H

    • Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. Diabetes September 1992 41:1130-1140; doi:10.2337/diabetes.41.9.1130

  7. Turner, R C

    • Elevated plasma concentrations of beta-cell tropin (ACTH22-39) in diet-treated type II diabetic patients. Diabetes September 1992 41:1160-1164; doi:10.2337/diabetes.41.9.1160

U

  1. Umemura, K

    • Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes September 1992 41:1165-1171; doi:10.2337/diabetes.41.9.1165

  2. Uusitupa, M

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

V

  1. Valyou, P M

    • Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes September 1992 41:1091-1099; doi:10.2337/diabetes.41.9.1091

  2. Vanninen, E

    • Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes September 1992 41:1069-1075; doi:10.2337/diabetes.41.9.1069

  3. Vranic, M

    • Banting Lecture: glucose turnover. A key to understanding the pathogenesis of diabetes (indirect effects of insulin). Diabetes September 1992 41:1188-1206; doi:10.2337/diabetes.41.9.1188

W

  1. Wiegmann, T B

    • Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes September 1992 41:1035-1041; doi:10.2337/diabetes.41.9.1035
    • Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat. Diabetes September 1992 41:1106-1112; doi:10.2337/diabetes.41.9.1106

  2. Wolny, J D

    • A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes September 1992 41:1084-1090; doi:10.2337/diabetes.41.9.1084

Z

  1. Zajarny, I U

    • Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes September 1992 41:1042-1049; doi:10.2337/diabetes.41.9.1042

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement